Common Contracts

COLLABORATION AND LICENSE AGREEMENT

Collaboration and License Agreement • July 9th, 2013 • Mirati Therapeutics, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Collaboration and License Agreement
• Filed
  July 9th, 2013
• Company
  Mirati Therapeutics, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This COLLABORATION AND LICENSE AGREEMENT (“Agreement”), effective as of this day of October 16, 2003 (the “Effective Date”), is made by and between Taiho Pharmaceutical Co., Ltd., a corporation organized under the laws of Japan, with a principal place of business at 1-27 Kandanishiki-cho, Chiyoda-ku, Tokyo 101-8444, Japan (“Taiho”), and MethylGene Inc., a corporation organized under the laws of Quebec, Canada with its principal place of business at 7220 Frederick-Banting, Suite 200, Montreal, Quebec H4S 2A1, Canada (“MG”). Each of Taiho and MG shall be referred to as a “Party,” and together as the “Parties.”

COLLABORATION AND LICENSE AGREEMENT

Collaboration and License Agreement • May 10th, 2013 • Mirati Therapeutics, Inc. • New York

• Contract Type
  Collaboration and License Agreement
• Filed
  May 10th, 2013
• Company
  Mirati Therapeutics, Inc.
• Jurisdiction
  New York

This COLLABORATION AND LICENSE AGREEMENT (“Agreement”), effective as of this day of October 16, 2003 (the “Effective Date”), is made by and between Taiho Pharmaceutical Co., Ltd., a corporation organized under the laws of Japan, with a principal place of business at 1-27 Kandanishiki-cho, Chiyoda-ku, Tokyo 101-8444, Japan (“Taiho”), and MethylGene Inc., a corporation organized under the laws of Quebec, Canada with its principal place of business at 7220 Frederick-Banting, Suite 200, Montreal, Quebec H4S 2A1, Canada (“MG”). Each of Taiho and MG shall be referred to as a “Party,” and together as the “Parties.”